Wikidata

(Q61956983)

English

Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children

clinical trial

In more languages

Statements

title
Immunogenicity and Safety Study of GlaxoSmithKline Biological's Live Attenuated Measles Mumps Rubella Varicella Vaccine (PriorixTetra™) When Co-administered With Conjugated Meningococcal C Vaccine (Meningitec®, Nuron Biotechs' Vaccine) in Healthy Children (English)
0 references
medical condition
measles
0 references
chickenpox
0 references
herpes zoster
0 references
rubella
0 references
sponsor
GSK
0 references
country
Italy
0 references
main subject
safety
0 references
child
0 references
start time
6 February 2012
0 references
end time
17 February 2014
0 references
number of participants
716
0 references
research site
GSK
0 references
minimum age
13 month
0 references
maximum age
15 month
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61956983&oldid=2074975320"